DaVita
DVA
#1828
Rank
$11.31 B
Marketcap
$176.35
Share price
0.82%
Change (1 day)
32.72%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): $12.48

According to DaVita's latest financial reports the company's current EPS (TTM) is $12.48. In 2025 the company made an earnings per share (EPS) of $10.12 a decrease over its 2024 EPS that were of $11.03.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)$12.4823.32%
2025$10.12-8.25%
2024$11.0344.94%
2023$7.6127.26%
2022$5.98-35.56%
2021$9.2844.1%
2020$6.4419.7%
2019$5.38540.48%
2018$0.84-76.07%
2017$3.51-19.31%
2016$4.35242.52%
2015$1.27-62.87%
2014$3.4213.43%
2013$3.018.45%
2012$2.78

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
$24.83 98.96%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
$12.17-2.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
$26.12 109.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
$2.12-83.04%๐Ÿ‡บ๐Ÿ‡ธ USA